ClinicalTrials.gg
CompletedNCT07627581Updated Sep 29, 2026

Foam Roller Versus Self-Performed Neurodynamic Sliding in People With Hamstring Tightness and Low Back Pain History

An interventional study of Self-Myofascial Release Using a Foam Roller and Self-Administered Neurodynamic Sliding Technique in Low Back Pain and Hamstring Tightness, sponsored by Universidad Pontificia de Salamanca. Completed at 1 site in Spain. Open to participants aged 18 Years to 65 Years. Per ClinicalTrials.gov, last updated 2026-09-29.

Sponsored by Universidad Pontificia de Salamanca · Not applicable, Interventional, and Treatment

How we know

Updated Sep 29, 2026Now CompletedPrimary completion moved+2 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
30
Allocation
Randomized
Ages
18 Years to 65 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 168 studies in Low Back Pain with a site in Spain — 20 open to participants now, 22 under way, 1 of them phase 3. Low Back Pain · Spain.

Enrollment
125th of 148
30 · median 60
Started
2026
with 7 others
No phase
131 of 168
17 open now
Registered
165th of 168
by date

Among the 168 studies in Low Back Pain with a site in Spain, this one is the 125th largest by enrollment of the 148 interventional ones that give a count, is one of 8 that started in 2026, is one of 131 with no phase, and was the 165th registered.

Low Back Pain

2,930 studies on the registry are indexed under Low Back Pain; 581 are open to participants now.

Browse Low Back Pain studies →

Open to participants now

20 of the 168 studies in Low Back Pain with a site in Spain are open now. Recruiting first, the newest first:

15 more — sign in →

All 20 open studies →

A study can be open while its sites in Spain have not opened yet or have stopped. Only those recruiting at a site in Spain →

Who these studies take

Of the 332 Low Back Pain studies recruiting now, 93 (28%) set no upper age limit and 209 (63%) stop at 75 or younger; 8 take children under 18; 46 take healthy volunteers.

This study: 18 Years to 65 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 168 studies in Low Back Pain with a site in Spain, or all of them as a file.
02

Study summary

This randomized crossover pilot clinical trial evaluated the effects of two self-administered physiotherapy techniques in people with hamstring tightness and a history of non-specific low back pain.

Participants were randomly assigned to one of two treatment sequences. One sequence performed self-myofascial release using a foam roller first, followed by a one-month washout period, and then performed a self-administered neurodynamic sliding technique. The other sequence performed the neurodynamic sliding technique first, followed by a one-month washout period, and then performed the foam roller intervention.

The main objective of the study was to compare the effects of both interventions on hamstring flexibility. Secondary outcomes included active knee extension range of motion, dynamic balance, pressure pain threshold, hamstring and gluteus maximus strength, and low back pain intensity.

Read the detailed description

Low back pain is a common musculoskeletal condition, and hamstring tightness has been proposed as a potential contributing factor due to its influence on pelvic and lumbar biomechanics. Different physiotherapy interventions may be used to improve hamstring flexibility, including self-myofascial release with a foam roller and neurodynamic sliding techniques.

This study was designed as a randomized, crossover, pilot clinical trial with two active interventions. Participants were people with hamstring tightness and a history of recurrent or chronic non-specific low back pain. Eligible participants were randomly assigned to one of two intervention sequences.

In one sequence, participants first performed self-myofascial release using a foam roller on the hamstring muscles. After a one-month washout period, they then performed the self-administered neurodynamic sliding technique. In the other sequence, participants first performed the self-administered neurodynamic sliding technique. After a one-month washout period, they then performed the self-myofascial release intervention using a foam roller.

The foam roller intervention consisted of bilateral self-myofascial release of the hamstring muscles for 2 minutes per leg over three consecutive days. The neurodynamic sliding intervention consisted of a seated self-administered neurodynamic sliding technique over three consecutive days, with 3 sets of 20 repetitions and 20 seconds of rest between sets.

Assessments were performed before and after each intervention period. The primary outcome was hamstring flexibility measured using the Straight Leg Raising test. Secondary outcomes included hamstring flexibility measured using the Active Knee Extension test, dynamic balance assessed with the Y-Balance Test, pressure pain threshold over myofascial trigger points, isometric strength of the hamstrings and gluteus maximus, and low back pain intensity measured with the Numeric Pain Rating Scale.

03

Conditions studied

  • Low Back Pain
  • Hamstring Tightness

Browse trials for

Keywords

  • foam roller
  • Self-myofascial release
  • Neurodynamic sliding
  • Hamstring flexibility
  • Low back pain
  • Crossover trial
04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Men and women aged 16 years or older.
  • History of non-specific low back pain during the previous three months and/or recurrent or chronic non-specific low back pain.
  • Limited hamstring flexibility, defined as hamstring tightness with 75 degrees or less of hip flexion with knee extension during the Straight Leg Raise test.
  • No previous surgery involving the spine or lower limb.
  • No hamstring stretching exercises performed in the weeks prior to participation.
  • Ability and willingness to provide .
  • Availability to perform both self-administered physiotherapy techniques according to the study protocol.

Exclusion criteria

Exclusion Criteria:

  • Pregnancy or breastfeeding.
  • History of hamstring muscle or tendon injury during the previous year.
  • Lumbar or lower-limb neurological deficits.
  • Lower-limb length discrepancy.
  • Specific spinal pathology, including tumor, infection, fracture, or inflammatory disease.
  • History of lumbar disc herniation.
  • History of whiplash injury.
  • Any to physical exercise.
  • Menstrual pain at the time of assessment or intervention.
  • Scheduled surgery during the intervention or follow-up period.
  • History of cardiac disease.
  • Incomplete or incorrectly completed questionnaires or missing assessment data.
  • Refusal to complete part or all of the study intervention.
  • Development of a low back pain episode during the study intervention.
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

Contraindication

A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Crossover assignment
Masking
Single (Outcomes assessor)
Enrollment
30 participants (actual)

Study arms

  • Experimental
    Foam Roller First, Then Neurodynamic Sliding

    Participants assigned to this sequence will first perform self-myofascial release using a foam roller on the hamstring muscles. After a one-month washout period, they will perform the self-administered neurodynamic sliding technique.

    Other: Self-Myofascial Release Using a Foam Roller · Other: Self-Administered Neurodynamic Sliding Technique

  • Experimental
    Neurodynamic Sliding First, Then Foam Roller

    Participants assigned to this sequence will first perform the self-administered neurodynamic sliding technique. After a one-month washout period, they will perform self-myofascial release using a foam roller on the hamstring muscles.

    Other: Self-Myofascial Release Using a Foam Roller · Other: Self-Administered Neurodynamic Sliding Technique

Interventions

  • OtherSelf-Myofascial Release Using a Foam Roller

    Participants will perform bilateral self-myofascial release of the hamstring muscles using a foam roller. The technique will be performed for 2 minutes per leg over three consecutive days.

  • OtherSelf-Administered Neurodynamic Sliding Technique

    Participants will perform a seated self-administered neurodynamic sliding technique over three consecutive days. The intervention will consist of 3 sets of 20 repetitions, with 20 seconds of rest between sets.

06

What researchers measure

Primary outcomes

  1. Change in Hamstring Flexibility Measured With the Straight Leg Raise Test

    Hamstring flexibility will be assessed using the Straight Leg Raise test. The test will be performed with the participant in the supine position, and hip flexion range of motion will be measured in degrees using a goniometer. Higher values indicate greater hamstring flexibility.

    Time frame: Baseline of each intervention period, 24 hours after completing each intervention, and 7 days after each intervention

Secondary outcomes

  1. Change in Hamstring Flexibility Measured With the Active Knee Extension Test

    Hamstring flexibility will be assessed using the Active Knee Extension test. The knee extension angle will be measured in degrees using a goniometer, with the hip positioned at 90 degrees of flexion.

    Time frame: Baseline of each intervention period, 24 hours after completing each intervention, and 7 days after each intervention

  2. Change in Dynamic Balance Measured With the Y-Balance Test

    Dynamic balance will be assessed using the Y-Balance Test. Reach distances in the anterior, posteromedial, and posterolateral directions will be recorded in centimeters and normalized to lower limb length.

    Time frame: Baseline of each intervention period, 24 hours after completing each intervention, and 7 days after each intervention

  3. Change in Pressure Pain Threshold

    Isometric strength of the hamstring muscles and gluteus maximus will be assessed using a handheld dynamometer. Values will be recorded in Newtons, with higher values indicating greater muscle strength.

    Time frame: Baseline of each intervention period, 24 hours after completing each intervention, and 7 days after each intervention

  4. Change in Low Back Pain Intensity

    Low back pain intensity will be assessed using the Numeric Pain Rating Scale, ranging from 0 to 10, where 0 indicates no pain and 10 indicates the worst imaginable pain.

    Time frame: Baseline of each intervention period, 24 hours after completing each intervention, and 7 days after each intervention

07

Study locations

1 site
  • Clínica Universitaria Salus Infirmorum, Universidad Pontificia de Salamanca
    Madrid, Madrid 28015, Spain
08

References and documents

Individual participant data

Plan to share: No — Individual participant data will not be shared because the study dataset contains health-related information collected in a small pilot trial. Data will be pseudonymized and stored according to applicable data protection regulations, but no formal data sharing plan has been established.

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it movedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Jun 2026 to primary completion in Jul 2026, 1 month.

Of 1,234 non-industry interventional studies with no phase under Low Back Pain, half reached primary completion within 11 months of starting (the median), counting those still running; a quarter within 4 and three quarters within 26. This study's 1 month is below that.

Counting every sponsor, half of 1,290 studies reached it within 11 months; a quarter within 5 and three quarters within 27.

Since we started tracking on Sep 25, 2026, the dates moved once, on Sep 29, 2026: primary completion Aug 2026 → Jul 2026 and completion Aug 2026 → Sep 2026.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
May 30, 2026
First posted
Jun 4, 2026
StartActual
Jun 2, 2026
Primary completionActual
Jul 12, 2026was Aug 2026
CompletionActual
Sep 10, 2026was Aug 2026
Last update
Sep 29, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Status
Not yet recruiting→Completed
changed Sep 29, 2026
Primary completion
Aug 2026→Jul 12, 2026 (actual)
Sep 29, 2026
Study completion
Aug 2026→Sep 10, 2026 (actual)
Sep 29, 2026
Show all 1 update
  1. Sep 29, 2026
    Not yet recruiting→Completed
    Primary completion Aug 2026→Jul 12, 2026 (now actual)
    Study completion Aug 2026→Sep 10, 2026 (now actual)
    + 2 other changes: verification date and contact details

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07627581
Lead sponsor
Universidad Pontificia de Salamanca
Responsible party
Sara Perpiñá (Principal investigator and Professor of Physiotherapy, Universidad Pontificia de Salamanca) — Principal investigator
First posted
Jun 4, 2026
Start date
Jun 2, 2026
Primary completion
Jul 12, 2026
Completion
Sep 10, 2026
Last update
Sep 29, 2026

Study contacts

Sara Perpiña Martínez, PT, PhD
principal investigator · Pontifical University of Salamanca

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Sep 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion